New Jersey to Receive $124.5 Million from Purdue Pharma Opioid Crisis Settlement

In a significant legal development, New Jersey is poised to receive $124.5 million as part of an extensive $7.4 billion settlement agreement involving Purdue Pharma and the Sackler family. This settlement is the culmination of efforts by all 55 attorneys general representing various states and U.S. territories. As announced by Connecticut Attorney General William Tong, the case marks a critical juncture in addressing the complexities of Purdue Pharma’s role in the opioid crisis. The financial deal further augments New Jersey’s achievements, with the state having amassed a total of $1.3 billion in settlements from cases tied to the opioid epidemic. For further details, visit the original article.